Skip to content
Avalo Therapeutics, Inc. (AVTX) Stock Price, Key Stats & Insider Trading
Home / Companies / AVTX AVT
Avalo Therapeutics, Inc. (AVTX) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest AVTX Insider Trades
About Avalo Therapeutics, Inc. (AVTX) Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
Headquarters WAYNE, PA
Employees 33
Listed 2015
Exchange XNAS https://www.avalotx.com SEC filings for AVTX on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 9 84,163 $1.68M Grant or award 10 172,454 Option exercise 18 161,270
AVTX Insider Transactions (Form 4) 64 62 Form 4 filings on record, the earliest from Nov 14, 2024, newest first. Filing history page 1 of 3.
Date Insider Transaction Security Shares Price Value Aug 17, 2026 CS Christopher Ryan Sullivan - Officer Option exercise Common Stock 37,945
Recent AVTX Form 8-K Filings 5
Recent AVTX Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 18, 2026 CHRISTOPHER RYAN SULLIVAN Officer 31,031 $622K View on EDGAR Aug 17, 2026 CHRISTOPHER RYAN SULLIVAN Officer
AVTX Insider Trading - FAQ
What is the latest insider trade for AVTX? Avalo Therapeutics, Inc. (AVTX) had 21 insider filings in the last 90 days, with the most recent on 2026-08-19. The full record for AVTX runs to 62 Form 4 filings, the earliest from 2024-11-14. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying AVTX stock? No insider purchases of AVTX were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling AVTX stock? 9 insider sales of AVTX were filed in the last 90 days, totaling $1.68M.
Where can I see AVTX SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks AVTX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow AVTX insider buys? Create a free InsiderAlpha account and press Watch on this page to add AVTX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track AVTX insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free
Market cap $1.05B
P/E ratio -
Dividend yield -
Average volume 1.30M
52 week high $24.27
52 week low $8.65
Today's high $20.18
Today's low $19.54
Open $19.87
Volume 738.3K
Previous close $20.05
Shares outstanding 53.63M Market cap
$1.05B
33 employees
AVTX Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 9 sales totaling $1.68M.
Most-Active AVTX Insiders - Last 90 Days 10 Tax withholding / forfeiture 4 2,891
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Aug 17, 2026 MD Mittie Doyle - Officer Option exercise Common Stock 1,000 $12.65 $13K
Aug 17, 2026 MD Mittie Doyle - Officer Open-market sale Common Stock 1,000 $20.00 $20K
Aug 17, 2026 MD Mittie Doyle - Officer Option exercise Stock Option (Right to Buy) 1,000 $0.00 -
Aug 11, 2026 JR Jennifer Riley - Officer Open-market sale Common Stock 2,655 $19.59 $52K
Aug 10, 2026 MD Mittie Doyle - Officer Option exercise Common Stock 679 $8.04 $5K
Aug 10, 2026 MD Mittie Doyle - Officer Open-market sale Common Stock 679 $20.00 $14K
Aug 10, 2026 MD Mittie Doyle - Officer Option exercise Stock Option (Right to Buy) 679 $0.00 -
Jul 27, 2026 MD Mittie Doyle - Officer Option exercise Common Stock 1,000 $12.65 $13K
Jul 27, 2026 MD Mittie Doyle - Officer Open-market sale Common Stock 1,000 $20.00 $20K
Jul 27, 2026 MD Mittie Doyle - Officer Option exercise Stock Option (Right to Buy) 1,000 $0.00 -
Jun 30, 2026 MD Mittie Doyle - Officer Option exercise Stock Option (Right to Buy) 2,875 $0.00 -
Jun 30, 2026 MD Mittie Doyle - Officer Option exercise Stock Option (Right to Buy) 1,779 $0.00 -
Jun 30, 2026 MD Mittie Doyle - Officer Option exercise Common Stock 2,875 $12.65 $36K
Jun 30, 2026 MD Mittie Doyle - Officer Option exercise Common Stock 1,779 $8.04 $14K
Jun 30, 2026 MD Mittie Doyle - Officer Open-market sale Common Stock 4,654 $20.00 $93K
Jun 30, 2026 RP Ron M. Philip Grant or award Stock Option (Right to Buy) 69 $15.04 $1K
Jun 30, 2026 KL Kevin Robert Lind Grant or award Stock Option (Right to Buy) 1,105 $15.04 $17K
Jun 30, 2026 RJ Rita Jain Grant or award Stock Option (Right to Buy) 1,080 $15.04 $16K
Jun 23, 2026 MD Mittie Doyle - Officer Option exercise Common Stock 1,450 $8.04 $12K
Jun 23, 2026 MD Mittie Doyle - Officer Open-market sale Common Stock 1,450 $18.00 $26K
Jun 23, 2026 MD Mittie Doyle - Officer Option exercise Stock Option (Right to Buy) 1,450 $0.00 -
Jun 23, 2026 RP Ron M. Philip Grant or award Stock Option (Right to Buy) 40,200 $0.00 -
Jun 10, 2026 JR Jennifer Riley - Officer Tax withholding / forfeiture Common Stock 588 $13.10 $8K
Jun 10, 2026 PV Paul Varki - Officer Tax withholding / forfeiture Common Stock 1,081 $13.10 $14K
Jun 10, 2026 MD Mittie Doyle - Officer Tax withholding / forfeiture Common Stock 1,084 $13.10 $14K
Jun 2, 2026 ST Samantha Truex Grant or award Stock Option (Right to Buy) 20,100 $0.00 -
Jun 2, 2026 GK Gilla Kaplan Grant or award Stock Option (Right to Buy) 20,100 $0.00 -
Jun 2, 2026 AK Aaron Kantoff Grant or award Stock Option (Right to Buy) 20,100 $0.00 -
Jun 2, 2026 RJ Rita Jain Grant or award Stock Option (Right to Buy) 20,100 $0.00 -
May 28, 2026 MD Mittie Doyle - Officer Option exercise Common Stock 679 $8.04 $5K
May 28, 2026 MD Mittie Doyle - Officer Open-market sale Common Stock 679 $16.00 $11K
May 28, 2026 MD Mittie Doyle - Officer Option exercise Stock Option (Right to Buy) 679 $0.00 -
May 21, 2026 JR Jennifer Riley - Officer Grant or award Common Stock 34,200 $0.00 -
May 21, 2026 PV Paul Varki - Officer Grant or award Common Stock 24,300 $0.00 -
May 21, 2026 MD Mittie Doyle - Officer Grant or award Common Stock 43,500 $0.00 -
May 15, 2026 MD Mittie Doyle - Officer Option exercise Common Stock 3,000 $12.65 $38K
May 15, 2026 MD Mittie Doyle - Officer Open-market sale Common Stock 3,000 $18.76 $56K
May 15, 2026 MD Mittie Doyle - Officer Option exercise Stock Option (Right to Buy) 3,000 $0.00 -
May 6, 2026 PV Paul Varki - Officer Option exercise Common Stock 62,500 $13.43 $839K
May 6, 2026 PV Paul Varki - Officer Option exercise Common Stock 12,563 $8.04 $101K
May 6, 2026 PV Paul Varki - Officer Open-market sale Common Stock 37,375 $18.91 $707K
May 6, 2026 PV Paul Varki - Officer Open-market sale Common Stock 5,196 $19.78 $103K
May 6, 2026 PV Paul Varki - Officer Open-market sale Common Stock 22,839 $21.22 $485K
May 6, 2026 PV Paul Varki - Officer Open-market sale Common Stock 9,253 $22.70 $210K
May 6, 2026 PV Paul Varki - Officer Open-market sale Common Stock 400 $23.71 $9K
May 6, 2026 PV Paul Varki - Officer Option exercise Stock Option (Right to Buy) 62,500 $0.00 -
May 6, 2026 PV Paul Varki - Officer Option exercise Stock Option (Right to Buy) 12,563 $0.00 -
$IONS
IONIS PHARMACEUTICALS INC
